Results 61 to 70 of about 83,228 (255)
Pharmacological treatment for psychotic depression [PDF]
, 2005 Evidence is limited regarding the most effective pharmacological treatment for psychotic depression: combination of an antidepressant plus an antipsychotic, monotherapy with an antidepressant or monotherapy with an antipsychotic. This is an update of a review first published in 2005 and last updated in 2009.1.
Wijkstra, J +4 more
openaire +4 more sources
Criminal Behaviour and Mental Health, EarlyView.ABSTRACT Background Prisoners experience poor mental health and well‐being in prison, including severe mental illnesses. However, access to mental health support and treatment in prison is limited. We conducted an integrative review to synthesise prisoners' experiences of living with mental ill health and/or seeking or receiving mental health support ...
Anne Kairu +5 more
wiley +1 more source
Cognitive Impairments in Depression with Different Psychotic Status
Вестник Московского университета. Серия 14: ПсихологияBackground. The study of cognitive functions in patients at high risk for psychosis is an urgent task for solving the problems of preventive intervention and early diagnosis of severe psychotic states.
Eugene R. Kafarov +6 more
doaj +1 more source
Copula‐based joint modelling of emergency department visits with time‐varying dependence
Canadian Journal of Statistics, EarlyView.Abstract Jointly modelling multiple correlated count time series is essential in health services research, where outcomes like emergency visits for mental health and substance use often evolve together. Ignoring these dependencies can obscure meaningful trends and limit the effectiveness of policy evaluation.
Guanjie Lyu, Cindy Feng, Lihui Liu
wiley +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples +10 more
wiley +1 more source
Drug Testing and Analysis, EarlyView.This review highlights the misuse of antidepressants as potential cognitive‐enhancing agents in Esports. Despite pharmacological effects that overlap with those of psychostimulants, antidepressants remain an under‐recognised source of doping in Esports.
Kassim Ali Salum +4 more
wiley +1 more source
Frontiers in PsychiatryPsychotic symptoms are prevalent in individuals with various mental health disorders and frequently lead to adverse outcomes. In this study, we assessed the prevalence of psychotic symptoms and its associated conditions in a large sample of Chinese ...
Jiamei Yuan +4 more
doaj +1 more source
Safe and Sound: Is Safeness a Specific Affective Dimension Related to Eating Disorder Behaviors?
International Journal of Eating Disorders, EarlyView.ABSTRACT Objective Safeness is a warm, soothing emotional state that is often experienced in the presence of close others. Safeness is thought to be distinct from other positive emotions or the absence of negative emotions and is shown to predict mental health variables over and above other emotions.
Ege Bicaker +3 more
wiley +1 more source
BMC PsychiatryBackground Major depressive disorder (MDD) is a common psychiatric disorder worldwide. Psychotic depression has been reported to be frequently under-diagnosed due to poor recognition of psychotic features.
Yuxuan Wu +10 more
doaj +1 more source